Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Crosslinked elastin and process for producing the same

a technology of elastin and crosslinked elastin, which is applied in the direction of prosthesis, animal/human proteins, peptide/protein ingredients, etc., can solve the problems of high stress, inadequate regeneration of nerve or blood vessel tissue,

Inactive Publication Date: 2006-09-14
CHISSO CORP
View PDF3 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0007] As a result of diligent research conducted in the light of these problems of the prior art, the present inventors have found that by crosslinking a water-soluble elastin with a crosslinking agent it is possible to obtain a crosslinked elastin having elasticity suitable for transplantation into the body while avoiding detachment of the coated cell adhesion proteins such as collagen or laminin, and the present invention has been completed on the basis of this finding.

Problems solved by technology

In the therapy method described above, the silicone tubes or polyurethane tubes or artificial blood vessels are coated with cell adhesion proteins such as collagen or laminin, but since the inner surfaces of the tubes have no cell adhesion properties, the cell adhesion proteins become detached with extended therapy resulting in inadequate regeneration of the nerve or blood vessel tissue.
Tubes or artificial blood vessels transplanted into an animal must be elastic so as to follow the movement of the body or tissue, but because tubes or artificial blood vessels composed mainly of silicone or polyester have a Young's modulus (elastic modulus) of 1×107 Pa or greater as compared to the Young's modulus (elastic modulus) of 1×104 to 2×106 Pa for the accommodating tissue, the joint is therefore subjected to high stress and can lead to such problems as thrombosis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crosslinked elastin and process for producing the same
  • Crosslinked elastin and process for producing the same
  • Crosslinked elastin and process for producing the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Water-Soluble Elastin

[0070] After adding 150 ml of 0.25 M oxalic acid to 20 g of powdered water-insoluble elastin (product of Elastin Products Company, Inc), the mixture was treated at 100° C. for 1 hour. After cooling, it was centrifuged (3000 rpm, 30 min) to separation, the supernatant was collected and placed in a cellulose dialysis tube (molecular cutoff: 6000-10,000), and dialysis was performed for 48 hours against deionized water to remove the oxalic acid. This was followed by lyophilization to obtain water-soluble elastin. The amino acid analysis results for the elastin starting material and the water-soluble elastin are shown in Table 1.

TABLE 1Water-solubleElastinelastin(mol %)(mol %)Aspartic acid0.6120.542Threonine0.7780.983Serine0.6650.964Glutamic acid1.6681.923Glycine33.2230.869Alanine22.7825.512Cysteine0.3760.562Valine13.37412.652Isoleucine2.5682.249Leucine6.2356.001Tyrosine0.7030.976Phenylalanine2.9673.023Lysine0.2790.381Histidine0.0370.063Arginine0.51...

example 2

Production of Crosslinked Elastin Using Glutaraldehyde as Crosslinking Agent

[0071] A 90 mg portion of the water-soluble elastin obtained in Example 1 was added to and dissolved in 161 μl of deionized water to obtain a water-soluble elastin aqueous solution. To this aqueous solution there was added 48.7 μl of 250 mM aqueous glutaraldehyde (product of Tokyo Kasei Kogyo Co., Ltd.), immediately producing a crosslinked elastin gel. It was attempted to cast the crosslinked elastin gel into a cylindrical molding template with a 2 mm diameter and 2 cm length, but the fluidity was too poor to allow casting. Casting into the template was difficult even when the amount of 250 mM aqueous glutaraldehyde addition was reduced to 1 / 10 the previous amount.

example 3

Production of Crosslinked Elastin Using Ethyleneglycol Diglycidyl Ether as Crosslinking Agent

[0072] A 36 mg portion of the water-soluble elastin obtained in Example 1 was added to and dissolved in 41.6 μl of deionized water to obtain a water-soluble elastin aqueous solution. To this aqueous solution there was added 42.4 μl of 287 mM aqueous ethyleneglycol diglycidyl ether, and upon thorough mixing, the solution was cast into a cylindrical template with a 2 mm diameter and 2 cm length and heated at 50° C. for one hour to obtain a crosslinked elastin gel. The obtained crosslinked elastin gel was thoroughly washed with deionized water, and upon conducting a simple stretching test by pulling with the fingers at both ends, it was found to be fragile against stretching deformation.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Reaction temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Login to View More

Abstract

A crosslinked elastin, a water-soluble crosslinking agent to be used for crosslinking, molded elastin articles, medical instruments and regeneration tissues using the crosslinked elastin, and a surgical therapy method and regeneration treatment wherein the medical instruments are employed. There is provided a biocompatible functional material having elasticity suitable for transplantation into the body without causing detachment of cell adhesion proteins.

Description

[0001] This application claims priority from Application Serial No. 2001-163,505, Filed on May 30, 2001 in Japan. This application also claims priority from PCT International Patent Application No. PCT / JP02 / 05275, Filed on May 30, 2002 and published on Dec. 5, 2002 as WO 02 / 096978 A1. This application is a Divisional of and claims priority from U.S. application Ser. No. 10 / 478,150, Filed: Nov. 19, 2003. The contents of the preceding applications are incorporated herein by reference for all purposes as fully set forth.FIELD OF THE INVENTION [0002] The present invention relates to a biocompatible functional material, and to its production process, medical instruments, crosslinking agents, surgical therapy methods and regeneration tissue. DESCRIPTION OF THE RELATED ART [0003] One method used to treat patients with severed nerve tissue resulting from accidents, disasters and other causes has been to ligate tubes made of artificial materials to the site of nerve deficiency to induce rege...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/39C07K14/78C09J189/00A61L27/22C08H1/06
CPCA61L27/227C08H1/06
Inventor KEIICHI, MIYAMOTO
Owner CHISSO CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com